Literature DB >> 33650817

lncRNA PVT1 Promotes Metastasis of Non-Small Cell Lung Cancer Through EZH2-Mediated Activation of Hippo/NOTCH1 Signaling Pathways.

S Hang Gan Zeng1, Jian-Hong Xie2, Qun-Ying Zeng2, S Hao Hua Dai1, Yun Wang1, Xue-Mei Wan3, Ji C Hun Liu4.   

Abstract

OBJECTIVE: Although growing evidences have showed that long non-coding RNA (lncRNAs) plasmacytoma variant translocation 1 (PVT1) plays a critical role in the progression of non-small cell lung cancer (NSCLC), there are still many unsolved mysteries remains to be deeply elucidated. This study aimed to find a new underlying mechanism of PVT1 in regulating the tumorigenesis and development of NSCLC.
MATERIALS AND METHODS: In this experimental study, Quantitative reverse transcription polymerase chain reaction (qRTPCR) was used to profile the expression of PVT1 in NSCLC tissues and cells. The effects of PVT1 on cell growth, migration and invasion were detected by colony formation assay, Matrigel-free transwell and Matrigel transwell assays, respectively. Changes of the key protein expression in Hippo and NOTCH signaling pathways, as well as epithelialmesenchymal transition (EMT) markers, were analyzed using western blot. Interaction of PVT1 with enhancer of zeste homolog 2 (EZH2) was verified by RNA pull-down, and their binding to the downstream targets was detected by Chromatin Immunoprecipitation (ChIP) assays.
RESULTS: These results showed that PVT1 was up-regulated in NSCLC tissue and cell lines, promoting NSCLC cell proliferation, migration and invasion. Knockdown of PVT1 inhibited the expression of Yes-associated protein 1 (YAP1) and NOTCH1 signaling activation. Further, we have confirmed that PVT1 regulated expression of YAP1 through EZH2-mediated miR-497 promoter methylation resulting in the inhibition of miR-497 transcription and its target YAP1 upregulation, and finally NOTCH signaling pathway was activated, which promoted EMT and invasion and metastasis.
CONCLUSION: These results suggested that lncRNA PVT1 promotes NSCLC metastasis through EZH2-mediated activation of Hippo/NOTCH1 signaling pathways. This study provides a new opportunity to advance our understanding in the potential mechanism of NSCLC development. Copyright© by Royan Institute. All rights reserved.

Entities:  

Keywords:  EZH2; NSCLC; PVT1; YAP1; miR-497

Year:  2021        PMID: 33650817      PMCID: PMC7944120          DOI: 10.22074/cellj.2021.7010

Source DB:  PubMed          Journal:  Cell J        ISSN: 2228-5806            Impact factor:   2.479


  35 in total

1.  lncRNA-PVT1 Facilitates Invasion Through Upregulation of MMP9 in Nonsmall Cell Lung Cancer Cell.

Authors:  Wei Chen; Huayun Zhu; Li Yin; Tingting Wang; Jianfeng Wu; Jianhua Xu; Hua Tao; Juying Liu; Xia He
Journal:  DNA Cell Biol       Date:  2017-07-21       Impact factor: 3.311

2.  Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions.

Authors:  Yuan Shen; Shanshan Liu; Jiao Fan; Yinghua Jin; Baolei Tian; Xiaofei Zheng; Hanjiang Fu
Journal:  EMBO Rep       Date:  2017-03-06       Impact factor: 8.807

3.  Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.

Authors:  Dong Guo; Yanli Wang; Kewei Ren; Xinwei Han
Journal:  Exp Cell Res       Date:  2017-11-11       Impact factor: 3.905

4.  Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer.

Authors:  Yang Wang; Qianze Dong; Qingfu Zhang; Zixuan Li; Enhua Wang; Xueshan Qiu
Journal:  Cancer Sci       Date:  2010-01-23       Impact factor: 6.716

5.  Alterations of the Notch pathway in lung cancer.

Authors:  Britta Westhoff; Ivan N Colaluca; Giovanni D'Ario; Maddalena Donzelli; Daniela Tosoni; Sara Volorio; Giuseppe Pelosi; Lorenzo Spaggiari; Giovanni Mazzarol; Giuseppe Viale; Salvatore Pece; Pier Paolo Di Fiore
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

6.  LncRNA PVT1 regulate expression of HIF1α via functioning as ceRNA for miR‑199a‑5p in non‑small cell lung cancer under hypoxia.

Authors:  Chunhong Wang; Chunfang Han; Yibo Zhang; Fengqin Liu
Journal:  Mol Med Rep       Date:  2017-11-03       Impact factor: 2.952

Review 7.  Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer.

Authors:  Dean Yimlamai; Brendan H Fowl; Fernando D Camargo
Journal:  J Hepatol       Date:  2015-07-28       Impact factor: 25.083

8.  cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth.

Authors:  Zirong Chen; Jian-Liang Li; Shuibin Lin; Chunxia Cao; Nicholas T Gimbrone; Rongqiang Yang; Dongtao A Fu; Miranda B Carper; Eric B Haura; Matthew B Schabath; Jianrong Lu; Antonio L Amelio; W Douglas Cress; Frederic J Kaye; Lizi Wu
Journal:  J Clin Invest       Date:  2016-05-03       Impact factor: 14.808

9.  The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer.

Authors:  Wei-Cheng Liang; Wei-Ming Fu; Cheuk-Wa Wong; Yan Wang; Wei-Mao Wang; Guo-Xin Hu; Li Zhang; Li-Jia Xiao; David Chi-Cheong Wan; Jin-Fang Zhang; Mary Miu-Yee Waye
Journal:  Oncotarget       Date:  2015-09-08

10.  The long non-coding RNA PVT1 represses ANGPTL4 transcription through binding with EZH2 in trophoblast cell.

Authors:  Yetao Xu; Yifan Lian; Yuanyuan Zhang; Shiyun Huang; Qing Zuo; Nana Yang; Yanzi Chen; Dan Wu; Lizhou Sun
Journal:  J Cell Mol Med       Date:  2017-11-29       Impact factor: 5.310

View more
  6 in total

Review 1.  The deadly cross-talk between Hippo pathway and epithelial-mesenchymal transition (EMT) in cancer.

Authors:  Ioanna Akrida; Vasiliki Bravou; Helen Papadaki
Journal:  Mol Biol Rep       Date:  2022-05-23       Impact factor: 2.742

2.  Long Noncoding RNA LINC01703 Exacerbates the Malignant Properties of Non-Small Cell Lung Cancer by Upregulating MACC1 in a MicroRNA-605-3p-Mediated Manner.

Authors:  Ziyi Wang; Xinyu Zhang; Xuedong Zhang; Xuedong Jiang; Wenya Li
Journal:  Oncol Res       Date:  2021-09-07       Impact factor: 5.574

3.  Long noncoding RNA NR2F1-AS1 stimulates the tumorigenic behavior of non-small cell lung cancer cells by sponging miR-363-3p to increase SOX4.

Authors:  Luming Jin; Chaoyang Chen; Lipeng Huang; Qingyu Sun; Liang Bu
Journal:  Open Med (Wars)       Date:  2021-12-16

Review 4.  The long and short non-coding RNAs modulating EZH2 signaling in cancer.

Authors:  Sepideh Mirzaei; Mohammad Hossein Gholami; Kiavash Hushmandi; Farid Hashemi; Amirhossein Zabolian; Israel Canadas; Ali Zarrabi; Noushin Nabavi; Amir Reza Aref; Francesco Crea; Yuzhuo Wang; Milad Ashrafizadeh; Alan Prem Kumar
Journal:  J Hematol Oncol       Date:  2022-03-02       Impact factor: 17.388

Review 5.  Notch-associated lncRNAs profiling circuiting epigenetic modification in colorectal cancer.

Authors:  Omnia Emam; Eman F Wasfey; Nadia M Hamdy
Journal:  Cancer Cell Int       Date:  2022-10-13       Impact factor: 6.429

Review 6.  lncRNA PVT1: a novel oncogene in multiple cancers.

Authors:  Ruiming Li; Xia Wang; Chunming Zhu; Kefeng Wang
Journal:  Cell Mol Biol Lett       Date:  2022-10-04       Impact factor: 8.702

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.